Fresenius Medical Care Geçmiş Kazanç Performansı
Geçmiş kriter kontrolleri 3/6
Fresenius Medical Care şirketinin kazançları yıllık ortalama -20.9% oranında azalırken, Healthcare sektörünün kazançları yıllık 5.8% oranında artan oldu. Gelirler yıllık ortalama 2.7% oranında artan oldu. Fresenius Medical Care şirketinin öz sermaye getirisi 5.9% olup, net marjı 3.4% dir.
Anahtar bilgiler
-20.9%
Kazanç büyüme oranı
-20.4%
EPS büyüme oranı
Healthcare Sektör Büyümesi | 15.7% |
Gelir büyüme oranı | 2.7% |
Özkaynak getirisi | 5.9% |
Net Marj | 3.4% |
Sonraki Kazanç Güncellemesi | 25 Feb 2025 |
Yakın geçmiş performans güncellemeleri
Recent updates
Fresenius Medical Care AG (ETR:FME) Not Flying Under The Radar
Nov 01We Think Fresenius Medical Care (ETR:FME) Is Taking Some Risk With Its Debt
Sep 26These Return Metrics Don't Make Fresenius Medical Care (ETR:FME) Look Too Strong
Sep 08At €34.34, Is Fresenius Medical Care AG (ETR:FME) Worth Looking At Closely?
Aug 20Fresenius Medical Care AG Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now
Aug 02These 4 Measures Indicate That Fresenius Medical Care (ETR:FME) Is Using Debt Extensively
Jun 17What You Can Learn From Fresenius Medical Care AG's (ETR:FME) P/E
May 30Some Shareholders May Object To A Pay Rise For Fresenius Medical Care AG's (ETR:FME) CEO This Year
May 10Fresenius Medical Care (ETR:FME) Is Increasing Its Dividend To €1.19
Apr 26Fresenius Medical Care's (ETR:FME) Shareholders Will Receive A Bigger Dividend Than Last Year
Mar 29Fresenius Medical Care (ETR:FME) Has Announced That It Will Be Increasing Its Dividend To €1.19
Mar 14Fresenius Medical Care's (ETR:FME) Dividend Will Be Increased To €1.19
Feb 23When Should You Buy Fresenius Medical Care AG (ETR:FME)?
Feb 22Market Participants Recognise Fresenius Medical Care AG's (ETR:FME) Earnings
Feb 03Fresenius Medical Care (ETR:FME) Could Be Struggling To Allocate Capital
Jan 16Is Fresenius Medical Care (ETR:FME) Using Too Much Debt?
Dec 29Is There Now An Opportunity In Fresenius Medical Care AG & Co. KGaA (ETR:FME)?
Nov 21Capital Allocation Trends At Fresenius Medical Care KGaA (ETR:FME) Aren't Ideal
Oct 16Is Fresenius Medical Care KGaA (ETR:FME) A Risky Investment?
Sep 28Is Now The Time To Look At Buying Fresenius Medical Care AG & Co. KGaA (ETR:FME)?
Aug 21An Intrinsic Calculation For Fresenius Medical Care AG & Co. KGaA (ETR:FME) Suggests It's 34% Undervalued
Jul 23Returns On Capital At Fresenius Medical Care KGaA (ETR:FME) Paint A Concerning Picture
Jul 09These 4 Measures Indicate That Fresenius Medical Care KGaA (ETR:FME) Is Using Debt Extensively
Jun 25What Does Fresenius Medical Care AG & Co. KGaA's (ETR:FME) Share Price Indicate?
May 07Is There An Opportunity With Fresenius Medical Care AG & Co. KGaA's (ETR:FME) 49% Undervaluation?
Apr 23We Think Fresenius Medical Care KGaA (ETR:FME) Is Taking Some Risk With Its Debt
Mar 24Gelir ve Gider Dağılımı
Fresenius Medical Care nasıl para kazanır ve harcar. LTM bazında en son bildirilen kazançlara dayanmaktadır.
Kazanç ve Gelir Geçmişi
Tarih | Gelir | Kazançlar | G+A Giderleri | Ar-Ge Giderleri |
---|---|---|---|---|
30 Sep 24 | 19,239 | 659 | 3,148 | 199 |
30 Jun 24 | 19,415 | 530 | 3,186 | 212 |
31 Mar 24 | 19,474 | 484 | 3,190 | 224 |
31 Dec 23 | 19,454 | 499 | 3,196 | 232 |
30 Sep 23 | 19,463 | 450 | 3,156 | 228 |
30 Jun 23 | 19,622 | 596 | 3,180 | 236 |
31 Mar 23 | 19,554 | 602 | 3,163 | 235 |
31 Dec 22 | 19,398 | 673 | 3,170 | 229 |
30 Sep 22 | 19,048 | 763 | 3,104 | 234 |
30 Jun 22 | 18,393 | 806 | 3,018 | 225 |
31 Mar 22 | 17,957 | 878 | 3,091 | 222 |
31 Dec 21 | 17,619 | 969 | 2,773 | 221 |
30 Sep 21 | 17,372 | 918 | 3,011 | 205 |
30 Jun 21 | 17,344 | 998 | 2,986 | 198 |
31 Mar 21 | 17,581 | 1,131 | 2,868 | 197 |
31 Dec 20 | 17,859 | 1,164 | 2,966 | 194 |
30 Sep 20 | 18,039 | 1,330 | 2,991 | 190 |
30 Jun 20 | 18,044 | 1,309 | 3,016 | 187 |
31 Mar 20 | 17,832 | 1,212 | 3,099 | 185 |
31 Dec 19 | 17,477 | 1,200 | 2,944 | 168 |
30 Sep 19 | 17,196 | 1,282 | 2,967 | 138 |
30 Jun 19 | 16,835 | 1,234 | 2,978 | 122 |
31 Mar 19 | 16,704 | 1,974 | 2,898 | 111 |
31 Dec 18 | 16,547 | 1,982 | 2,857 | 114 |
30 Sep 18 | 16,676 | 1,951 | 3,126 | 131 |
30 Jun 18 | 16,954 | 1,975 | 3,185 | 133 |
31 Mar 18 | 17,211 | 1,250 | 3,374 | 130 |
31 Dec 17 | 17,784 | 1,280 | 3,640 | 111 |
30 Sep 17 | 17,771 | 1,249 | 3,417 | 134 |
30 Jun 17 | 17,647 | 1,244 | 3,407 | 145 |
31 Mar 17 | 17,201 | 1,239 | 3,262 | 144 |
31 Dec 16 | 16,570 | 1,144 | 3,133 | 147 |
30 Sep 16 | 16,101 | 1,063 | 3,047 | 143 |
30 Jun 16 | 15,841 | 998 | 3,027 | 136 |
31 Mar 16 | 15,402 | 933 | 2,961 | 130 |
31 Dec 15 | 15,455 | 955 | 2,895 | 128 |
30 Sep 15 | 15,345 | 939 | 2,919 | 118 |
30 Jun 15 | 15,246 | 948 | 2,839 | 114 |
31 Mar 15 | 15,428 | 977 | 2,816 | 115 |
31 Dec 14 | 13,329 | 864 | 2,434 | 101 |
30 Sep 14 | 12,413 | 839 | 2,242 | 97 |
30 Jun 14 | 11,112 | 775 | 1,999 | 91 |
31 Mar 14 | 10,882 | 791 | 1,962 | 91 |
31 Dec 13 | 10,816 | 806 | 1,937 | 91 |
Kaliteli Kazançlar: FME yüksek kaliteli kazançlar sağlıyor.
Büyüyen Kar Marjı: FME 'nin mevcut net kar marjları (3.4%) geçen yılın (2.3%) sinden daha yüksektir.
Serbest Nakit Akışı ve Kazanç Analizi
Geçmiş Kazanç Büyüme Analizi
Kazanç Eğilimi: FME şirketinin kazançları son 5 yılda yılda 20.9% oranında azaldı.
Büyüme Hızlandırma: FME 'un son bir yıldaki kazanç büyümesi ( 46.5% ) 5 yıllık ortalamasını (yıllık -20.9% ) aşıyor.
Kazançlar vs. Sektör: FME geçen yılki kazanç büyümesi ( 46.5% ) Healthcare sektörünün 50.8% performansını geride bırakmadı.
Özkaynak Getirisi
Yüksek ROE: FME 'nin Özsermaye Getirisi ( 5.9% ) düşük olarak değerlendiriliyor.